Development and validation of a simple stability-indicating LC-method and UVA photostability study of desonide hair lotion

Current Analytical Chemistry

Volumn 9, Issue 4, 2013, Pages 659-667

  Santa, Fabrícia Dalla ^a   Sperotto, Laura Escher ^a   Braga, Muriele Picoli ^a   Dalcin, Tássia Cristina Silveira ^a   Codevilla, Cristiane Franco ^b   Meneghini, Leonardo Zanchetti ^b   Donato, Eliane Maria ^b   Rolim, Clarice Madalena Bueno ^a   Bergold, Ana Maria ^b   Adams, Andréa Inês Horn ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Desonide; Desonide assay; Desonide hair lotion; Desonide photostability; Desonide stability; Validation

Indexed keywords

DRUG PRODUCTS; QUALITY CONTROL;

ACTIVE PHARMACEUTICALS INGREDIENTS; DESONIDE; DESONIDE ASSAY; DESONIDE HAIR LOTION; DESONIDE PHOTOSTABILITY; DESONIDE STABILITY; PHOTO-STABILITY; SIMPLE++; STABILITY-INDICATING; VALIDATION;

STABILITY;

EID: 84898078463     PISSN: 15734110     EISSN: 18756727     Source Type: Journal    
DOI: 10.2174/15734110113099990011     Document Type: Article

References (18)

1. Del Rosso, J.; Friedlander, S. F. Corticosteroids: options in the era of steroidsparing therapy. J. Am. Acad. Dermatol., 2005, 53(1), S50-S58.
2. Eichenfield, L. F.; Basu, S.; Calvarese, B.; Trancik, R. J. Effect of Desonide Hydrogel 0. 05% on the Hypothalamic-Pituitary-Adrenal Axis in Pediatric Subjects with Moderate to Severe Atopic Dermatitis. Ped. Dermatol., 2007, 24(3), 289-295.
3. Bhankharia, D. A.; Sanjana, P. H. Efficacy of desonide 0. 05% cream and lotion in steroid-responsive dermatoses in Indian patients: A post-marketing surveillance study. Indian J. Dermatol. Venereol. Leprol., 2004, 70(5), 288-291.
4. Wong, V. K.; Fuchs, B.; Lebwohl, M. Overview on desonide 0. 05%: a clinical safety profile. J. Drugs Dermatol., 2004, 3, 393-397.
5. Hebert, A. A. & The Desonide Foam Phase III Clinical Study Group. Desonide foam 0. 05%: Safety in children as young as 3 months. J. Am. Acad. Dermatol., 2008, 59(2), 334-340.
6. Pujos, E.; Flament-Waton, M. M.; Paisse, O.; Grenier-Loustalot, M. F. Comparison of the analysis of corticosteroids using different techniques. Anal. Bioanal. Chem., 2005, 381(1), 244-254.
7. Mazzarino, M.; Torre, X.; Botrè, F. A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in hu man urine by LC-ESI-MS/MS. Anal. Bioanal. Chem., 2008, 392(4), 681-698.
8. Dikunets, M. A.; Appolonova, S. A.; Rodchenkov, G. M. Simultaneous Determination of a Broad Spectrum of Nonconjugated Xenobiotics by High-Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Anal. Chem., 2008, 64, 854-864.
9. Yoshioka, S.; Stella, V. J. Stability of Drugs and Dosage Forms; Kluwer Academic Publishers: New York, 2002.
10. Iqbal, J., Husain, A.; Gupta, A. Photochemistry of desonide, a nonfluorinated steroidal anti-inflammatory drug. Chem. Pharm. Bull., 2006, 54(6), 836-838.
11. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline on Stability Testing of New Drugs Substances and Products, 2003, Geneva, Switzerland.
12. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline on Validation of Analytical Procedures: Text and Methodology, 2005, Geneva, Switzerland.
13. Watson, D. G. Pharmaceutical Analysis. A Textbook for Pharmacy Students and Pharmaceutical Chemists; Elsevier Churchill Livingstone: Edinburgh, 2005.
14. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline on Stability Testing: Photostability Testing of New Drug Substances and Products, 1996, Geneva, Switzerland.
15. Shabir, G. A. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization.
16. 2003. J. Chromatogr. A, 2003, 987(1-2): 57-66.
17. United States Food and Drug Administration (US-FDA). Reviewer Guidance: Validation of Chromatographic Methods. 1994.
18. Tønnesen, H. H. Photostability of drugs and drug formulations; CRC Press: New York, 2004.